# Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

> **NCT06938945** · NA · RECRUITING · sponsor: **Wei Xiaoping** · enrollment: 500 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **BEHAVIORAL:** Digitized patient-reported outcomes

## Key facts

- **NCT ID:** NCT06938945
- **Lead sponsor:** Wei Xiaoping
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-24
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-09-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938945, "Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06938945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*